Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial metabolism: a common link between neuroinflammation and neurodegeneration
Debapriya Garabadu, Nidhi Agrawal, Anjali Sharma, et al.
Behavioural Pharmacology (2019) Vol. 30, Iss. 8, pp. 641-651
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Cognitive Impairment in Parkinson’s Disease: Epidemiology, Clinical Profile, Protective and Risk Factors
Paulina Gonzàlez‐Latapi, Ece Bayram, Irene Litvan, et al.
Behavioral Sciences (2021) Vol. 11, Iss. 5, pp. 74-74
Open Access | Times Cited: 71
The PI3K-AKT pathway: A plausible therapeutic target in Parkinson's disease
Ahsas Goyal, Anant Agrawal, Aanchal Verma, et al.
Experimental and Molecular Pathology (2022) Vol. 129, pp. 104846-104846
Open Access | Times Cited: 64
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview
Analı́a Bortolozzi, Giovanna Fico, Michael Berk, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 323-357
Open Access | Times Cited: 10
Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium
Kosma Sakrajda, Aleksandra Szczepankiewicz
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1532-1532
Open Access | Times Cited: 44
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
Ana Bernal‐Chico, Vanja Tepavčević, Andrea Manterola, et al.
Glia (2022) Vol. 71, Iss. 1, pp. 103-126
Open Access | Times Cited: 29
Systemic alterations of tricarboxylic acid cycle enzymes in Alzheimer’s disease
Dongdong Jia, Fangzhou Wang, Haitao Yu
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 17
Glucagon-like peptide-1 analogs mitigate neuroinflammation in Alzheimer's disease by suppressing NLRP2 activation in astrocytes
Mengjun Zhang, Yubin Wu, Ruonan Gao, et al.
Molecular and Cellular Endocrinology (2021) Vol. 542, pp. 111529-111529
Closed Access | Times Cited: 39
Novel Therapeutic Target for Prevention of Neurodegenerative Diseases: Modulation of Neuroinflammation with Sig-1R Ligands
Ferenc Bogár, Lívia Fülöp, Botond Penke
Biomolecules (2022) Vol. 12, Iss. 3, pp. 363-363
Open Access | Times Cited: 22
Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency
Cristina Solana‐Manrique, F. Sanz, Isabel Torregrosa, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 331-331
Open Access | Times Cited: 21
Polyphenols from the flower of Hibiscus syriacus Linn ameliorate neuroinflammation in LPS-treated SH-SY5Y cell
Rongrong Zhang, Rui-Dan Hu, Xinyi Lu, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110517-110517
Open Access | Times Cited: 28
3D biocomposite culture enhances differentiation of dopamine-like neurons from SH-SY5Y cells: A model for studying Parkinson's disease phenotypes
Nicholas J. Fiore, Jackson D. Tamer-Mahoney, Afshin Beheshti, et al.
Biomaterials (2022) Vol. 290, pp. 121858-121858
Open Access | Times Cited: 18
REPS1 as a Potential Biomarker in Alzheimer’s Disease and Vascular Dementia
Jiefeng Luo, Liechun Chen, Xiaohua Huang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 17
Therapeutic implications of crocin in Parkinson's disease: A review of preclinical research
Ahsas Goyal, Aanchal Verma, Anant Agrawal, et al.
Chemical Biology & Drug Design (2023) Vol. 101, Iss. 6, pp. 1229-1240
Closed Access | Times Cited: 10
Correlations of blood and brain NMR metabolomics with Alzheimer’s disease mouse models
Franz Knörnschild, Ella Zhang, Rajshree Ghosh Biswas, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
CPT1A in AgRP neurons is required for sex-dependent regulation of feeding and thirst
Sebastián Zagmutt, Paula Mera, Ismael González‐García, et al.
Biology of Sex Differences (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Saffron, a Potential Bridge between Nutrition and Disease Therapeutics: Global Health Challenges and Therapeutic Opportunities
Rakeeb Ahmad Mir, Anshika Tyagi, Sofi Javed Hussain, et al.
Plants (2024) Vol. 13, Iss. 11, pp. 1467-1467
Open Access | Times Cited: 3
Urinary kynurenine as a biomarker for Parkinson’s disease
Jia-he Bai, Ya-li Zheng, Yong-Peng Yu
Neurological Sciences (2020) Vol. 42, Iss. 2, pp. 697-703
Closed Access | Times Cited: 23
Human Gray and White Matter Metabolomics to Differentiate APOE and Stage Dependent Changes in Alzheimer’s Disease
Tyler C. Hammond, Xin Xing, Lucy M Yanckello, et al.
Journal of Cellular Immunology (2021) Vol. 3, Iss. 6
Open Access | Times Cited: 19
How Inflammation Pathways Contribute to Cell Death in Neuro-Muscular Disorders
Sara Salucci, Anna Bartoletti Stella, Michela Battistelli, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1109-1109
Open Access | Times Cited: 14
Combined Treatment of Dichloroacetic Acid and Pyruvate Increased Neuronal Survival after Seizure
Song Hee Lee, Bo Young Choi, A Ra Kho, et al.
Nutrients (2022) Vol. 14, Iss. 22, pp. 4804-4804
Open Access | Times Cited: 10
Whole blood mitochondrial copy number in clinical populations with mood disorders: A meta-analysis
Cali A. Calarco, Swarnapali M. Keppetipola, Gautam Kumar, et al.
Psychiatry Research (2023) Vol. 331, pp. 115662-115662
Open Access | Times Cited: 5
Neurobehavioral alterations in a mouse model of chronic partial sleep deprivation
Shiyana Arora, Ravinder Naik Dharavath, Yashika Bansal, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 6, pp. 1315-1330
Closed Access | Times Cited: 12
Neuroprotective Effects and Therapeutic Potential of Dichloroacetate: Targeting Metabolic Disorders in Nervous System Diseases
Yue Zhang, Meiyan Sun, Hongxiang Zhao, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 7559-7581
Open Access | Times Cited: 4
Review of nanotheranostics for molecular mechanisms underlying psychiatric disorders and commensurate nanotherapeutics for neuropsychiatry: The mind knockout
Rajiv Kumar, Bhupender S. Chhikara, Kiran Gulia, et al.
Nanotheranostics (2021) Vol. 5, Iss. 3, pp. 288-308
Open Access | Times Cited: 10
Association of stressful life events with cognitive impairment in patients with type 2 diabetes mellitus
Lina Wang, Shanshan Dong, Chenxu Zhao, et al.
Journal of Diabetes Investigation (2023) Vol. 14, Iss. 6, pp. 792-800
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top